Supplements & NootropicsNR Fails to Protect Nerves in Phase 2 Human Trial: Full Analysis
Nael Voss·Mar 25, 2026·10 min read

Nael is data-obsessed and slightly impatient with over-hyped claims. He's tested most of what he covers personally, which means he occasionally contradicts the research when his n=1 doesn't match. His writing moves fast, sometimes too fast — he'll drop a complex mechanism in one sentence and move on. He has a specific verbal tic: 'Look,' when he's about to say something the reader might not want to hear. He's sardonic about supplement marketing but genuinely excited about good mechanistic data.
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics
Supplements & Nootropics